Majority of patients who received TIPS had a complete clinical response ...

Cirrhosis is not a condition that can be reversed overnight, but it is also not always a fixed endpoint. With the right ...

A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy ...

A digital monitoring system for advanced cirrhosis may help detect deterioration earlier and reduce hospital admissions.

Resolution Therapeutics has welcomed new four‑year follow‑up data from the University of Edinburgh’s MATCH trial, which ...

A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing ...

Four-year follow-up data from the University of Edinburgh’s MATCH study, led by Resolution Therapeutics’ founder Professor Stuart Forbes, ...

A new type of cell therapy which could offer “real hope” to patients with advanced liver disease has been welcomed by a liver charity. Researchers said results from a clinical trial suggest that the ...

Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...

Cirrhosis of the liver is a serious condition, causing scarring and permanent damage to the liver. Life expectancy depends on the stage and type of liver cirrhosis, but it may vary between roughly ...

An estimated 6 to 8 million Americans are living with metabolic dysfunction-associated steatohepatitis, or MASH, the most ...